Fig. 2From: The efficacy and safety of tenecteplase compared with alteplase in adult patients with acute ischemic stroke: an updated systematic review and meta-analysis of ten randomized controlled trialsForest plots of efficacy outcome measures. A Early neurological improvement; B Recanalization; C mRS 0–1 at 90-days; and D mRS 0–2 at 90-days. TNK Tenecteplase, tPA Alteplase, CI Confidence interval, mRS modified Rankin Scale; Statistical significance considered at p < 0.05Back to article page